PRL-3 and MMP9 Expression and Epithelial-Mesenchymal Transition Markers in Circulating Tumor Cells From Patients With Colorectal Cancer: Potential Value in Clinical Practice.

Front Oncol · 2022 · PMC9104807 · PMID 35574414

Europe PMC DOI

hedged sentence

0.0890

closest p · 1.8× alpha

0.0890

boldest claim

The sentences

did not reach statistical significanceP= 0.089so close (0.05 < p ≤ 0.1)

Although the difference did not reach statistical significance (P= 0.089), those with positive expression had a higher rate of metastasis (71.3% vs 85.7%) compared with the patients with negative PRL-3 and MMP9 expression in CTCs.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.